Title : A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer.

Pub. Date : 2020 Sep 15

PMID : 32611648






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A biomarker-enriched, randomized Phase II trial of adavosertib (AZD1775) plus paclitaxel and carboplatin for women with platinum-sensitive TP53-mutant ovarian cancer. Platinum tumor protein p53 Homo sapiens